Guide · Updated September 2026

Why Is Ozempic So Much Cheaper Outside the US?

The Peterson-KFF Health System Tracker puts Ozempic's US list price at roughly five times Japan's and about ten times the price in the UK, Australia, France, and Sweden. Wegovy runs nearly four times Germany's price. The gap is real, and it isn't a manufacturing difference. Here's what causes it, and why importing the drug yourself is riskier than it sounds.

I hear a version of “why don’t I just order it from Canada” constantly. The price gap is real enough that the question makes sense. The answer is more complicated than a shipping label.

The price gap, by the numbers

Country	Ozempic (approx. monthly list price)	Wegovy (approx. monthly list price)	How prices are set
United States	~$936-$1,000	$1,349	Manufacturer sets list price, no government negotiation
Germany	Not independently confirmed here	~$328	Government price-setting/reference pricing
Japan	~$169	Not independently confirmed here	National health insurance price-setting
UK, Australia, France, Sweden	Roughly a tenth of the US price	Not independently confirmed here	National health systems negotiate or set prices directly

Figures reported by the Peterson-KFF Health System Tracker and corroborated by multiple independent health-policy outlets as of 2026. Exact figures shift with exchange rates and each country’s own negotiated updates, so treat these as the current order of magnitude, not a fixed quote.

Why the gap exists

It isn’t that Novo Nordisk and Eli Lilly manufacture a different, cheaper product for other countries. The molecule is identical. What’s different is who sets the price.

Countries like the UK, Germany, Japan, Australia, and France run national health systems (or systems with a dominant national payer) that negotiate drug prices directly with manufacturers, often using formal health-technology assessments to decide what a drug’s benefit is worth before agreeing to pay for it. If a manufacturer wants access to that country’s market, it accepts the negotiated price or doesn’t sell there.

The US has no equivalent. Drug manufacturers set their own US list price, and the fragmented mix of private insurers, PBMs, and government programs each negotiate separately, with none holding the kind of single-payer bargaining power a national health system has. For the mechanics of what happens instead, our guide on GLP-1 pricing covers the patent, manufacturing, and PBM-rebate side of the US number specifically.

This isn’t unique to GLP-1s. It’s the same pattern seen across most brand-name drugs sold in the US versus peer nations, and it’s been the subject of a US Senate inquiry into GLP-1 pricing specifically.

Want the current US cash-pay numbers instead?

See Current Cheapest US Prices →

Can you just buy it from Canada?

This is where most articles on this topic stop short. Here’s the legal picture.

Under federal law, it’s technically illegal for an individual to import a prescription drug into the US. In practice, the FDA has a long-standing personal importation policy under which it generally uses enforcement discretion not to act against travelers or individuals importing a roughly 90-day supply for personal use, when the drug treats a serious condition, isn’t available domestically in that form, and doesn’t present an unreasonable safety risk.

The catch that matters specifically for GLP-1s: semaglutide and tirzepatide are biologics, not small-molecule chemical drugs. Biologics have historically gotten different, less consistent treatment under both the personal importation enforcement-discretion framework and the formal wholesale importation pathway created by federal drug-importation law. Insulin (also a biologic) has a long history of de facto tolerance for personal-use import that GLP-1s don’t yet have. That means the “millions of Americans already do this safely” reasoning people apply to insulin doesn’t automatically transfer to Ozempic or Wegovy. This is a gray area, not a guaranteed safe harbor, and enforcement practice can change.

There’s also a supply problem working against you. Reporting on the Canadian pharmacy market describes tighter export practices around high-demand GLP-1s since 2025, partly a response to Canadian shortages tied to American demand. A Canadian pharmacy that will ship you a real product, at a real discount, consistently, is a narrower list than the ads suggest. Stick to CIPA-certified pharmacies if you go this route at all, and understand you’re accepting legal and supply ambiguity that a domestic purchase doesn’t carry.

Compare legitimate US options before looking abroad

Browse the Provider Directory →

What closes the gap domestically

The honest answer for most US patients isn’t importation. It’s using the channels already built to bring the US price down closer to what other countries pay:

Manufacturer direct cash-pay programs. NovoCare Pharmacy and LillyDirect sell Wegovy and Zepbound at $149-$449/month depending on dose, with no insurance or PBM markup involved. See our savings guide for the exact current terms.
Manufacturer savings cards, if you have qualifying commercial insurance, which can bring an eligible copay down to $25-$150/month.
The Medicare GLP-1 Bridge, if you’re a qualifying Medicare Part D beneficiary. Our Medicare coverage guide covers eligibility.
Patient assistance programs, if you’re uninsured and income-qualified for the specific drug’s foundation.

None of these get you to Germany’s $328 or Japan’s $169. They do get most patients meaningfully closer than the $1,349 list price, without the legal and supply-chain uncertainty of importing a biologic.

Bottom Line

Ozempic and Wegovy cost dramatically more in the US than in peer countries because those countries negotiate or set drug prices nationally and the US does not, not because of any difference in the drug itself. Importing from Canada sits in a genuine legal gray area for GLP-1s specifically, since biologics don’t get the same consistent import tolerance insulin has, and Canadian export controls have tightened besides. For most US patients, the realistic path to a lower price is one of the domestic cash-pay or assistance programs already covered elsewhere on this site, not a cross-border workaround.

FAQ

Why is Ozempic so much cheaper in Canada, the UK, or Japan?

Those countries negotiate or directly set drug prices through national health systems before a manufacturer can sell there. The US has no equivalent single-payer negotiation, so manufacturers set the US list price on their own. The drug itself is identical.

Is it legal to buy Ozempic or Wegovy from a Canadian pharmacy?

It’s a gray area. The FDA generally uses enforcement discretion to not act against personal-use imports of about a 90-day supply for serious conditions, but semaglutide and tirzepatide are biologics, which have historically received less consistent treatment under that policy than a small-molecule pill would. This is not a guaranteed safe harbor.

How much cheaper is Ozempic in other countries, exactly?

Based on the Peterson-KFF Health System Tracker, Ozempic’s US list price runs roughly five times Japan’s and about ten times the price in the UK, Australia, France, and Sweden. Wegovy runs close to four times Germany’s price. Exact figures shift with exchange rates and each country’s own updates.

Can I get in trouble for importing GLP-1 medication for personal use?

Federal law technically prohibits it, though the FDA doesn’t typically pursue individuals importing a small personal-use quantity of a drug treating a serious condition. The biologic status of semaglutide and tirzepatide makes this less clear-cut than it is for many other medications, and Canadian export restrictions add a separate supply risk on top of the legal one.

What’s the fastest legitimate way to lower my GLP-1 cost in the US?

Check the manufacturer’s direct cash-pay program (NovoCare Pharmacy or LillyDirect) and a manufacturer savings card if you have qualifying commercial insurance. Together these usually beat both the US list price and most compounded alternatives for brand-name Wegovy or Zepbound.

Guides:

Compare: All Providers · All Guides